Table 3.
Outcome data.
| CRP < 5 mg/dL Early Surgery (n = 304) |
CRP > 5 md/dL Early Surgery (n = 112) |
CRP > 5 mg/dL Delayed Surgery (n = 109) |
p-Value | |
|---|---|---|---|---|
| Implant type n (%) | 0.112 | |||
| Hemiprosthesis | 235 (77.3%) | 92 (82.1%) | 94 (86.2%) | |
| Totalendoprosthesis | 69 (22.7%) | 20 (17.9%) | 15 (13.8%) | |
| PJI | 8 (2.6%) | 2 (1.8%) | 4 (3.7%) | 0.657 |
| Prolonged wound healing | 17 (5.6%) | 4 (3.6%) | 7 (6.4%) | 0.667 |
| UTI | 37 (12.2%) | 10 (8.9%) | 22 (20.2%) | 0.035 |
| Pneumonia | 5 (1.6%) | 5 (4.5%) | 11 (10.1%) | <0.001 |
| Antbiotics post-OP | 97 (31.9%) | 32 (28.6%) | 79 (72.5%) | <0.0001 |
| Hospital stay (days, m, IQR) | 16 (12;20) | 16 (13;22) | 23 (16;26) | <0.001 |
| Mortality | 42 (13.8%) | 21 (18.8%) | 26 (23.9%) | 0.048 |